share_log

Needham Maintains Buy on Surmodics, Lowers Price Target to $44

Needham Maintains Buy on Surmodics, Lowers Price Target to $44

Needham维持对Surmodics的买入,将目标股价下调至44美元
Benzinga ·  2023/11/08 17:10

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and lowers the price target from $50 to $44.

Needham分析师迈克·马特森维持Surmodics(纳斯达克股票代码:SRDX)的买入,并将目标股价从50美元下调至44美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发